RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis

LEXINGTON, Mass., Nov 05, 2008 -- RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, today announced that it has shipped its new RDT 1000 instrument and Sequence Enrichment application to The Genome Center (GC) at the Washington University School of Medicine in St. Louis, a world leader in [...]

Celera and Abbott Enter Collaboration to Identify Pharmacogenomic Markers

Celera Corporation (NASDAQ:CRA) today announced that it has entered into a research collaboration with Abbott to identify genetic markers for one of Abbott's investigational compounds. A key aim of the collaboration is to investigate if genetic variants Celera has identified can predict how patients may respond to treatment. The identification of treatment response markers may [...]

First Inverted Routine Microscope with LED Light Source

First Inverted Routine Microscope with LED Light Source Leica DM IL LED Combines Brilliant Optics with Innovative Illumination Wetzlar, Germany. Brilliant optics and optimum illumination are the key to achieving the best possible results in microscopy. The Leica DM IL LED is the first inverted routine microscope to combine superlative Leica HC optics with state-of-the-art [...]

Roche NimbleGen Offers Comprehensive Epigenomic and Transcriptional Regulation Tools with HD2 (2.1 Million Probes) Arrays and Services

Roche NimbleGen has expanded its growing line of tools for analyzing the epigenome and genome-wide transcriptional regulation mechanisms by launching HD2 (2.1 million probes) arrays and services for chromatin immunoprecipitation (ChIP-chip). NimbleGen ChIP-chip HD2 arrays now provide more than a 5-fold increase in probe density per array, which allows for increasing the coverage of key [...]

Thermo Fisher Scientific to Collaborate with Genentech on Novel Technology Enabling Development of siRNA Therapeutics

Thermo Fisher Scientific Inc., the world leader in serving science, has entered into a collaboration with Genentech, Inc. to develop novel small-interfering RNA (siRNA) therapeutic technologies for indications of interest to Genentech. Under the collaboration agreement, Thermo Fisher Scientific will provide Genentech with siRNA design, stabilization, delivery and related RNA interference (RNAi) technologies from its [...]

INFICON Introduces HAPSITE ER Chemical ID System

Newest Person-Portable GC/MS for Rapid Analysis of Toxic Chemicals in the Field Syracuse, NY — November 4, 2008: INFICON introduces the new HAPSITE ER, its next generation of the only person-portable GC/MS for immediate, on-site investigation and analysis of volatile organic compounds (VOCs) in air, water and soil at parts per trillion (ppt) for most [...]

Osmetech Announces CYP450 2C9 Test Launch

Osmetech plc (LSE:OMH), the international molecular diagnostics company announces the launch of a genetic test for CYP450 2C9 drug metabolism. CYP450 2C9, or CYP2C9, is an important member of the Cytochrome P450 family of enzymes responsible for detoxifying potentially hazardous chemicals, such as drugs, that are "foreign" to the body. The CYP2C9 gene is important [...]

Invitrogen Corporation (NASDAQ:IVGN – News) today announced progress against its integration plans regarding its pending merger with Applied Biosystems.

The company announced that three members of the Applied Biosystems’ Board of Directors have been named to the Board of the new company, effective upon closing. The new members are: George F. Adam, Jr., Chairman of Recondo Technology, Inc.; Arnold J. Levine, Ph.D., professor at the Institute for Advanced Study; and William H. Longfield, retired [...]

Vacci-Test Signs New World-Wide Food Safety Licence with MagnaBioSciences

Vacci-Test Corporation ("Vacci-Test") is pleased to announce that it has completed a new exclusive licence agreement with MagnaBioSciences LLC ("MBS") of San Diego, California that gives Vacci-Test the world wide rights to the patented MBS magnetic technology for the detection of pathogens in the human food chain. The new agreement expands the terms of the [...]

Smiths Detection Develops Diagnostic System for Infectious Diseases

London, UK, 4 November 2008 - Smiths Detection today announces that it is developing a rapid diagnostic system, initially for use in hospital screening programmes for infectious diseases such as MRSA and Clostridium difficile. The Bio-Seeq system will provide easy-to-use tests suitable for either a laboratory or Point of Care setting where it can be [...]

Access IBO on Knowledge Center